Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand

BACKGROUND: Thalidomide based regimen is an effective and well tolerated therapy in multiple myeloma (MM) patients, however, there were a small number of studies written about the results of thalidomide therapy in non-transplant MM patients. We therefore conducted a retrospective study of 42 consecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Niparuck, Pimjai, Sorakhunpipitkul, Ladda, Atichartakarn, Vichai, Chuncharunee, Suporn, Ungkanont, Artit, Aungchaisuksiri, Pantep, Puavilai, Teeraya, Jootar, Saengsuree
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828404/
https://www.ncbi.nlm.nih.gov/pubmed/20051128
http://dx.doi.org/10.1186/1756-8722-3-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828404/
https://www.ncbi.nlm.nih.gov/pubmed/20051128
http://dx.doi.org/10.1186/1756-8722-3-1

Ejemplares similares